Optimal combination of immune cells for predicting outcomes in ESCC patients following neoadjuvant

Peipei Wang1, Yueyun Chen2, Lin Lu1

  • 1Department of Oncology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, Guangdong 510180, China.

Genes & Diseases
|July 12, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos